UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000008024
Receipt No. R000009438
Scientific Title Phase II clinical trial of combination chemotherapy with bendamustine and rituximab for relapsed or refractory CD20 positive indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma patients
Date of disclosure of the study information 2012/06/04
Last modified on 2016/11/26 15:15:54

No. Disposal Last modified on Item of update
1 Insert 2012/05/24 18:14:26
2 Update 2012/07/26 08:23:45 Recruitment status
Anticipated trial start date
3 Update 2012/07/26 08:28:25 Research ethics review
4 Update 2013/12/22 14:40:11 Email
Email
5 Update 2014/04/10 16:39:25 Recruitment status
6 Update 2016/11/26 15:14:55 Key inclusion criteria
7 Update 2016/11/26 15:15:54 Name of primary sponsor
Organization


Contact us.